Leadership Overview
BD has 10 executives leading key functions including strategy, technology, finance, marketing, and revenue.
Driven by innovation, BD is dedicated to advancing medical technology to improve patient outcomes and healthcare efficiency globally.
Driven by innovation, BD is dedicated to advancing medical technology to improve patient outcomes and healthcare efficiency globally.
Leadership Roles at BD
Tom Polen - Chairman, Chief Executive Officer & President
Tom Polen, the Chairman, Chief Executive Officer & President at BD, directs the company's overarching strategy and global operations. Polen guides BD's mission to advance medical technology, focusing on innovations that enhance patient safety, drug delivery, diagnostics, and biosciences. This leadership role involves setting the strategic vision for the company's diverse portfolio of medical devices, diagnostic systems, and laboratory equipment. Polen ensures alignment across all business units, driving growth and operational excellence to support hospitals, laboratories, and healthcare providers worldwide. The Chairman, Chief Executive Officer & President also oversees relationships with key stakeholders and the Board of Directors, solidifying BD's market position. Under Polen's direction, BD continues to expand its impact on global healthcare delivery, fostering a culture of innovation and commitment to improving health outcomes for patients everywhere. Tom Polen's executive oversight ensures the company remains at the forefront of medical advancements.

Thomas Spoerel - Senior VP, Finance & Chief Financial Officer, Regions
Thomas Spoerel, the Senior VP, Finance & Chief Financial Officer, Regions at BD, directs financial strategy and operations across BD's global regional markets. Spoerel oversees financial planning, analysis, and reporting, ensuring fiscal health and driving profitable growth in diverse geographic areas. This critical role supports BD's mission to provide innovative medical technologies and healthcare solutions worldwide. The Senior VP, Finance & Chief Financial Officer, Regions manages regional financial performance, optimizing resource allocation to support the company's objectives in patient safety, drug delivery, diagnostics, and biosciences. Spoerel collaborates with regional leadership teams to implement financial controls and identify opportunities for market expansion. By ensuring sound financial management, Thomas Spoerel underpins BD's ability to invest in research and development and maintain its leadership position in the medical technology industry. Spoerel's financial acumen is vital for BD's sustained global success.
Vitor Roque - Executive Vice President & Chief Financial Officer
Vitor Roque, the Executive Vice President & Chief Financial Officer at BD, oversees the company's comprehensive financial strategy and management. Roque directs all aspects of financial planning, accounting, treasury, and investor relations, ensuring the fiscal integrity and long-term financial health of BD. This pivotal role supports BD's global operations in developing and manufacturing advanced medical technologies, diagnostic systems, and laboratory equipment. The Executive Vice President & Chief Financial Officer plays a key part in capital allocation, driving investments in innovation that advance patient safety, drug delivery, and biosciences. Roque collaborates closely with the CEO and other executive leaders to guide strategic financial decisions, optimize profitability, and enhance shareholder value. By maintaining rigorous financial discipline, Vitor Roque ensures BD can continue its mission to improve healthcare outcomes worldwide. Roque's financial leadership is fundamental to BD's sustained growth and market leadership.
Ravi Dawar - Director, Finance & Chief Financial Officer
Ravi Dawar, the Director, Finance & Chief Financial Officer at BD, manages key financial operations and contributes to the company's fiscal strategy. Dawar oversees financial reporting, budgeting, and analysis, ensuring accuracy and compliance across financial activities. This role supports BD's broader financial objectives in developing and delivering innovative medical technologies and healthcare solutions. The Director, Finance & Chief Financial Officer plays a part in financial planning and resource allocation, aiding the company's efforts in patient safety, drug delivery, and diagnostics. Dawar collaborates with finance teams to maintain financial discipline and support strategic initiatives aimed at growth and operational efficiency. By ensuring sound financial practices, Ravi Dawar contributes to the stability and success of BD's global operations. Dawar's financial oversight supports BD's mission.
Denise Fleming - Chief Information Officer & Global Executive VP, Technology & Services
Denise Fleming, the Chief Information Officer & Global Executive VP, Technology & Services at BD, architects the company's global technology infrastructure and digital transformation initiatives. Fleming oversees the integration of advanced IT solutions across BD's operations, ensuring seamless data flow and robust cybersecurity measures. This executive leadership position is critical for supporting BD's development and manufacturing of medical devices, diagnostic systems, and laboratory equipment. Fleming drives innovation in technology services, enhancing the efficiency and effectiveness of healthcare solutions provided to hospitals, laboratories, and providers. The Chief Information Officer & Global Executive VP, Technology & Services also manages the strategic deployment of digital tools that improve patient safety and drug delivery systems. By optimizing technological resources, Fleming ensures BD maintains its competitive edge in the medical technology sector. Denise Fleming's strategic vision empowers BD's global reach through cutting-edge technology.
Meera Gopalakrishnan - Senior Vice President and Global Chief Marketing Officer
Meera Gopalakrishnan, the Senior Vice President and Global Chief Marketing Officer at BD, shapes and executes BD's global marketing strategies. Gopalakrishnan leads initiatives to enhance brand visibility and market penetration for BD's extensive range of medical devices, diagnostic systems, and healthcare solutions. This executive position is central to communicating the value of BD's innovations in patient safety, drug delivery, and biosciences to healthcare providers and laboratories worldwide. The Senior Vice President and Global Chief Marketing Officer oversees market research, product positioning, and integrated marketing campaigns designed to drive customer engagement and revenue growth. Gopalakrishnan ensures that BD's marketing efforts accurately reflect the company's commitment to advancing medical technology and improving global health outcomes. Meera Gopalakrishnan's leadership strengthens BD's market presence and reinforces its reputation as a leader in the medical technology sector.

Jillian Streeter - Manager, Quality & Chief Marketing Officer, Instrument
Jillian Streeter, the Manager, Quality & Chief Marketing Officer, Instrument at BD, leads critical quality assurance functions and spearheads marketing efforts for BD's instrument division. Streeter ensures that all instrument products meet stringent quality standards, directly impacting patient safety and diagnostic accuracy. Concurrently, Streeter drives the marketing strategy for these instruments, enhancing their market position and adoption by laboratories and healthcare providers. This dual role is essential for BD's commitment to delivering reliable medical devices and diagnostic systems. The Manager, Quality & Chief Marketing Officer, Instrument oversees quality control processes and develops targeted marketing campaigns that highlight the technological advancements and clinical benefits of BD's instrument portfolio. Streeter's focus on both quality and market impact ensures that BD's instrument offerings remain competitive and trusted. Jillian Streeter's leadership reinforces BD's reputation for excellence in both product quality and market engagement.
Devon Peterson - Director and Chief of Staff To Chief Revenue Officer
Devon Peterson, the Director and Chief of Staff To Chief Revenue Officer at BD, provides strategic support and operational coordination for the Chief Revenue Officer. Peterson facilitates the execution of revenue-generating strategies across BD's global sales and commercial operations. This role is integral to optimizing BD's market engagement and driving growth for its medical devices, diagnostic systems, and healthcare solutions. The Director and Chief of Staff To Chief Revenue Officer ensures alignment between sales teams, marketing efforts, and product development, enhancing the overall customer experience. Peterson manages key projects and initiatives that support revenue targets, contributing directly to BD's mission of advancing medical technology. By streamlining operations and enhancing communication, Devon Peterson empowers the Chief Revenue Officer to maximize commercial success and expand BD's impact on global healthcare. Peterson's support is crucial for BD's commercial effectiveness.
Elizabeth McCombs - Executive Vice President & Chief Technology Officer
Elizabeth McCombs, the Executive Vice President & Chief Technology Officer at BD, leads the company's technological innovation and research and development efforts. McCombs directs the strategic vision for BD's technology roadmap, focusing on pioneering advancements in medical devices, diagnostic systems, and laboratory equipment. This executive leadership role is fundamental to BD's mission of improving patient safety, drug delivery, and biosciences through cutting-edge solutions. The Executive Vice President & Chief Technology Officer oversees the development of next-generation technologies that address critical healthcare challenges globally. McCombs fosters a culture of innovation, encouraging collaboration between R&D teams and other business units to accelerate product development and market introduction. By driving technological excellence, Elizabeth McCombs ensures BD remains at the forefront of the medical technology industry, delivering impactful solutions to healthcare providers worldwide. McCombs's technical leadership shapes BD's future.

Michael Feld - Executive Vice President & Chief Revenue Officer
Michael Feld, the Executive Vice President & Chief Revenue Officer at BD, directs BD's global revenue generation strategies and commercial operations. Feld oversees all sales, business development, and customer relationship management functions, driving growth across BD's diverse portfolio of medical technologies and healthcare solutions. This executive leadership position is critical for maximizing market penetration and achieving revenue targets in hospitals, laboratories, and healthcare systems worldwide. The Executive Vice President & Chief Revenue Officer ensures seamless integration of sales and marketing efforts to deliver exceptional value to customers. Feld focuses on expanding BD's market share by identifying new opportunities and strengthening existing client partnerships. By optimizing the revenue engine, Michael Feld directly contributes to BD's mission of advancing medical technology and improving global health outcomes. Feld's commercial leadership is key to BD's financial success.
Explore Leadership Teams in Manufacturing
Biomerics designs, develops, and produces medical devices for diagnostic and interventional procedures. Their services include engineering, advanced components, and full contract manufacturing. Their headquarters is in Salt Lake City, Utah.
Company Leadership GB
WT
BM
CM
Advita Ortho, headquartered in Gainesville, Florida, is a global medical device company dedicated to advancing patient lives through innovative orthopedic solutions. Officially launched in November 2025, the company delivers high-quality orthopedic implants and a comprehensive suite of integrated surgical technologies powered by data, artificial intelligence, and machine learning. Advita Ortho owns and distributes established product lines including the Equinoxe Shoulder, Vantage Ankle, Alteon Hip, Truliant Knee, Newton balancing technology, and GPS navigation systems, among others. The company's portfolio creates an ecosystem designed to enhance surgical decision-making in the operating room while driving efficiency for healthcare systems. Led by industry veterans and backed by investment firms including Strategic Value Partners, Stellex Capital Management, and Greywolf Capital Management, Advita Ortho positions itself as a trusted partner to orthopedic surgeons worldwide, providing tools and technologies designed to improve patient outcomes and quality of life.
Company Leadership



Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body.
Company Leadership KB

SM
JC
Globus Medical, Inc. is a leading musculoskeletal solutions company and is driving significant technological advancements across a complete suite of products. Founded in 2003, Globus single-minded focus on advancing surgery has made it the fastest growing company in the history of orthopedics. Globus is driven to utilize superior engineering and technology to achieve pain free, active lives for all patients.
Company Leadership
KK
NJ
